openPR Logo
Press release

Government Shutdown Pauses MSPB Deadlines - But Federal Employees Face a Dangerous "Multiple Clock" Trap, Warns Leading Employment Attorney

10-02-2025 03:48 PM CET | Associations & Organizations

Press release from: ABNewswire

Federal Employment Attorney Justin Schnitzer: Government Shutdown Pauses MSPB Deadlines, But Beware Others

Federal Employment Attorney Justin Schnitzer: Government Shutdown Pauses MSPB Deadlines, But Beware Others

EEOC and OSC Deadlines Keep Running, Says Attorney Justin Schnitzer
Washington, D.C. - October 2, 2025 - As the Merit Systems Protection Board (MSPB) goes dark during the federal government shutdown, thousands of federal employees facing termination or discipline confront a confusing and potentially rights-threatening situation: which deadlines are paused, and which are still running?

Federal employment attorney [https://www.fedelaw.com/] Justin Schnitzer is warning employees that other employment-law clocks keep ticking regardless of whether the MSPB is open.

While the MSPB has suspended operations [https://www.mspb.gov/publicaffairs/press_releases/Shutdown_Press_Release_Oct12025.pdf] and extended its filing deadlines, critical timelines in other venues such as the Equal Employment Opportunity Commission (EEOC) remain in effect. Federal employees have a 45-day deadline to contact an EEO counselor for discrimination claims and a two-year statute of limitation under the Back Pay Act and Federal Tort Claims Act.

A Perfect Storm for Federal Employees

The timing of this shutdown compounds the risk. The MSPB has already received nearly 12,000 appeals in fiscal year 2025-a dramatic surge driven by proposed reductions in force (RIFs) across multiple agencies. When the Board reopens, even a brief shutdown will create a fresh backlog on top of an already strained system.

"Employees who wait until the MSPB reopens will face months-long delays in getting their cases heard," Schnitzer warned. "And if you're one day late on an EEO or OSC deadline while you were waiting for the MSPB to reopen, you may find yourself with no forum at all."

Why Attorneys Say "The Clock Keeps Ticking"

Despite the MSPB's deadline-pause language, experienced federal employment attorneys routinely advise clients to "act as if the clock never stopped." Schnitzer explains why:

"First, professional responsibility demands we take the most protective approach. Second, the current administration is allowing RIF implementation work to continue during the shutdown. Third, the exact calculation of how shutdown days affect deadlines that started before the shutdown is legally unclear, making early filing the safest approach."

What Federal Employees Should Do Now

Schnitzer offers three critical action steps:

*
Don't wait. If you've received a termination or adverse action notice, consult with a federal employment attorney immediately to identify ALL applicable deadlines-not just the MSPB appeal window.

*
Consider filing now if possible. Certified mail and overnight delivery to the MSPB's physical address may still be timestamped, eliminating any future dispute about timeliness.

*
Protect parallel rights. Even if you plan to file an MSPB appeal later, ensure you preserve your EEO, OSC, and other claims by meeting their separate deadlines.

"This shutdown creates complexity precisely when federal employees are most vulnerable," Schnitzer said. "The worst strategy is to assume everything is on hold. The safest strategy is to treat every deadline as if it's still active-and get experienced counsel to help you navigate all of them."

Attorney Justin Schnitzer [https://www.fedelaw.com/] represents federal employees in cases of employment violations just as he would want to be represented, all with the aim of achieving decisive victories. His passion for employment law and the fight for fundamental fairness began when he served as a judicial intern for the Equal Employment Opportunity Commission. He is admitted to the State Bar of Maryland.

Media Contact
Company Name: The Law Office of Justin Schnitzer
Contact Person: Justin Schnitzer
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=government-shutdown-pauses-mspb-deadlinesbut-federal-employees-face-a-dangerous-multiple-clock-trap-warns-leading-employment-attorney]
Phone: (202) 952-5860
Address:1212 Reisterstown Rd Suite 204
City: Pikesville
State: MD
Country: United States
Website: https://www.fedelaw.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Government Shutdown Pauses MSPB Deadlines - But Federal Employees Face a Dangerous "Multiple Clock" Trap, Warns Leading Employment Attorney here

News-ID: 4206315 • Views:

More Releases from ABNewswire

Case Quota Revolutionizes Legal Marketing with AI-Powered Strategies for Attorney Market Dominance
Case Quota Revolutionizes Legal Marketing with AI-Powered Strategies for Attorne …
Case Quota, the legal marketing division of S3 Events LLC, introduces cutting-edge AI technology to transform how attorneys compete in their markets. Led by a former top Los Angeles consultant with extensive Thomson Reuters experience, the company delivers streamlined processes that help law firms achieve market leadership through advanced digital strategies. The legal profession stands at a pivotal moment where traditional marketing approaches are rapidly becoming obsolete, and Case Quota is
PD-1 NSCLC Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Genor Biopharma, Shandong Boan Biotechnology, Pfizer, AstraZeneca, Lepu Biopharma
PD-1 NSCLC Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial L …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, PD-1 Non-Small Cell Lung Cancer pipeline constitutes 30+ key companies continuously working towards developing 30+ PD-1 Non-Small Cell Lung Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The PD-1 Non-Small Cell Lung Cancer Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to
Rheumatoid Arthritis Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | AbbVie, Pfizer, Regeneron/Sanofi, Eli Lilly and Company, UCB BIOSCIENCES GmbH
Rheumatoid Arthritis Market to Experience Notable Growth in Forecast Span by 203 …
The Key Rheumatoid Arthritis Companies in the market include - Eli Lilly and Company/Incyte Corporation, AbbVie, Cyxone, IGM Biosciences, Regeneron/Sanofi, UCB BIOSCIENCES GmbH, AbbVie, Pfizer, Changchun GeneScience Pharma, Novartis, Istituto Giannina Gaslini, and others. The Rheumatoid Arthritis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Rheumatoid Arthritis pipeline products will significantly revolutionize the Rheumatoid Arthritis market dynamics. DelveInsight's "Rheumatoid
Rheumatoid Arthritis Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | AbbVie, Pfizer, Regeneron/Sanofi, Eli Lilly and Company, UCB BIOSCIENCES GmbH
Rheumatoid Arthritis Market to Experience Notable Growth in Forecast Span by 203 …
The Key Rheumatoid Arthritis Companies in the market include - Eli Lilly and Company/Incyte Corporation, AbbVie, Cyxone, IGM Biosciences, Regeneron/Sanofi, UCB BIOSCIENCES GmbH, AbbVie, Pfizer, Changchun GeneScience Pharma, Novartis, Istituto Giannina Gaslini, and others. The Rheumatoid Arthritis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Rheumatoid Arthritis pipeline products will significantly revolutionize the Rheumatoid Arthritis market dynamics. DelveInsight's "Rheumatoid

All 5 Releases


More Releases for MSPB

Federal Employment Law Firm of Aaron D Wersing PLLC supports federal employees i …
United States, 25th Sep 2025 - When federal employees face workplace challenges, they need strong legal guidance from a firm that truly understands the complexities of federal employment law. The Federal Employment Law Firm of Aaron D. Wersing PLLC, located in Houston, TX, has built a reputation as one of the most trusted firms for handling cases related to federal employment disputes, disciplinary actions, discrimination, and workplace rights. With a